These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 22147903

  • 21. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement.
    Yamabe S, Dohi Y, Higashi A, Kinoshita H, Sada Y, Hidaka T, Kurisu S, Shiode N, Kihara Y, HERO (Hiroshima Heart Study Group) Investigators.
    Heart Vessels; 2016 Sep; 31(9):1497-503. PubMed ID: 26531830
    [Abstract] [Full Text] [Related]

  • 22. The decrease in QRS amplitude after aortic valve replacement in patients with aortic valve stenosis.
    Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nakama Y, Maruhashi T, Kagawa E, Dai K, Matsushita J, Ikenaga H.
    J Electrocardiol; 2009 Sep; 42(5):410-3. PubMed ID: 19368931
    [Abstract] [Full Text] [Related]

  • 23. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J, for Investigators study VIIDA.
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [Abstract] [Full Text] [Related]

  • 24. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

  • 25. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES.
    Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
    [Abstract] [Full Text] [Related]

  • 26. [Value of the electrocardiographic Cornell criteria for detecting left ventricular hypertrophy in elderly men].
    Zeng XZ, Liu DP, He Q, Guo HL, Fang F, Liu DG, Dong R, Zeng HY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):56-8. PubMed ID: 19671355
    [Abstract] [Full Text] [Related]

  • 27. Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement.
    Angeli F, Verdecchia P, Angeli E, Poeta F, Sardone M, Bentivoglio M, Prosciutti L, Cocchieri M, Zollino L, Bellomo G, Rondoni F, Garognoli O, Lenti S, Frigerio C, Gattobigio R, Benemio G, Biscottini B, Panciarola R, Buccolieri M, Liberati R, Trottini M, Cipollini F, Gemelli F, Schillaci G, Porcellati C.
    J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):812-6. PubMed ID: 17060807
    [Abstract] [Full Text] [Related]

  • 28. Prognostic value of energy loss index in asymptomatic aortic stenosis.
    Bahlmann E, Gerdts E, Cramariuc D, Gohlke-Baerwolf C, Nienaber CA, Wachtell K, Seifert R, Chambers JB, Kuck KH, Ray S.
    Circulation; 2013 Mar 12; 127(10):1149-56. PubMed ID: 23357717
    [Abstract] [Full Text] [Related]

  • 29. Implication of Different ECG Left Ventricular Hypertrophy in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Yang Y, Ahn JM, Kang DY, Ko E, Kim S, Kim TO, Kim JH, Lee J, Lee SA, Kim DH, Kim HJ, Kim JB, Choo SJ, Park SJ, Park DW.
    J Am Heart Assoc; 2022 Feb 15; 11(4):e023647. PubMed ID: 35112886
    [Abstract] [Full Text] [Related]

  • 30. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K.
    Circulation; 2007 Aug 14; 116(7):700-5. PubMed ID: 17664372
    [Abstract] [Full Text] [Related]

  • 31. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Ibsen H, Kjeldsen SE, Lyle PA, Devereux RB.
    J Hum Hypertens; 2007 Aug 14; 21(8):625-32. PubMed ID: 17476291
    [Abstract] [Full Text] [Related]

  • 32. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
    Olsen MH, Wachtell K, Ibsen H, Lindholm LH, Dahlöf B, Devereux RB, Kjeldsen SE, Oikarinen L, Okin PM, LIFE Study Investigators.
    J Hypertens; 2006 Apr 14; 24(4):775-81. PubMed ID: 16531808
    [Abstract] [Full Text] [Related]

  • 33. Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction.
    Barrabés JA, Figueras J, Cortadellas J, Lidón RM, Ibars S.
    Am J Cardiol; 2009 Feb 15; 103(4):455-60. PubMed ID: 19195501
    [Abstract] [Full Text] [Related]

  • 34. Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure.
    Okin PM, Wachtell K, Gerdts E, Dahlöf B, Devereux RB.
    J Hypertens; 2014 Dec 15; 32(12):2472-8; discussion 2478. PubMed ID: 25340854
    [Abstract] [Full Text] [Related]

  • 35. Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study).
    Gerdts E, Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber C, Ray S, Skjærpe T, Wachtell K, Willenheimer R.
    Am J Cardiol; 2010 Dec 01; 106(11):1634-9. PubMed ID: 21094366
    [Abstract] [Full Text] [Related]

  • 36. Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
    Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Dahlöf B, LIFE Study Investigators.
    Circulation; 2006 Jan 03; 113(1):67-73. PubMed ID: 16365195
    [Abstract] [Full Text] [Related]

  • 37. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E, Okin PM, Boman K, Wachtell K, Nieminen MS, Dahlöf B, Devereux RB.
    Am J Hypertens; 2012 Jun 03; 25(6):678-83. PubMed ID: 22456225
    [Abstract] [Full Text] [Related]

  • 38. The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy.
    Verdecchia P, Angeli F, Cavallini C, Mazzotta G, Repaci S, Pede S, Borgioni C, Gentile G, Reboldi G.
    J Hypertens; 2009 Aug 03; 27(8):1697-704. PubMed ID: 19424088
    [Abstract] [Full Text] [Related]

  • 39. Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study).
    Verdecchia P, Reboldi G, Di Pasquale G, Mazzotta G, Ambrosio G, Yang S, Pogue J, Wallentin L, Ezekowitz MD, Connolly SJ, Yusuf S, RE-LY Study Investigators.
    Am J Cardiol; 2014 Feb 15; 113(4):669-75. PubMed ID: 24359765
    [Abstract] [Full Text] [Related]

  • 40. Influence of atypical symptoms and electrocardiographic signs of left ventricular hypertrophy or ST-segment/T-wave abnormalities on the natural history of otherwise asymptomatic adults with moderate to severe aortic stenosis: preliminary communication.
    Hering D, Piper C, Horstkotte D.
    J Heart Valve Dis; 2004 Mar 15; 13(2):182-7. PubMed ID: 15086255
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.